Evidence map›Paper›PMID 35112188›Full record

ArticleActa diabetologica2022

Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes.

Serena Pezzilli, Tommaso Mazza, Maria Giovanna Scarale, Yaling Tang, Francesco Andreozzi, Marco Giorgio Baroni, Raffaella Buzzetti, Maria Gisella Cavallo, Efisio Cossu, Paola D'Angelo and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta diabetologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Monogenic diabetes.Nature reviews. Disease primers · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 2 countries.

Serena PezzilliResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Tommaso MazzaUnit of Bioinformatics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Maria Giovanna ScaraleResearch Unit of Diabetes and Endocrine Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Yaling TangResearch Division, Joslin Diabetes Center, Boston, MA, USA.
Francesco AndreozziDepartment of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Marco Giorgio BaroniDepartment of Clinical Medicine, Health & Environmental Sciences, University of L'Aquila, L' Aquila, Italy.
Raffaella BuzzettiDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Maria Gisella CavalloDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Efisio CossuDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Paola D'AngeloUnit of Diabetology, Sandro Pertini Hospital, Rome, Italy.
Salvatore De CosmoDepartment of Medicine, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
Olga LamacchiaUnit of Endocrinology, Department of Medical and Surgical Sciences, University Hospital of Foggia, Foggia, Italy.
Frida LeonettiDiabetes Unit, Department of Medical-Surgical Sciences and Biotechnologies, Santa Maria Goretti Hospital, Sapienza University of Rome, Latina, Italy.
Susanna MoranoDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Lelio MorviducciUnit of Diabetology, S. Spirito Hospital-AslRM1, Rome, Italy.
Giuseppe PennoSection of Diabetes and Metabolic Disease, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Paolo PozzilliDepartment of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.
Giuseppe PuglieseDepartment of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Giorgio SestiDepartment of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Alessandro DoriaResearch Division, Joslin Diabetes Center, Boston, MA, USA.
Vincenzo TrischittaResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Sabrina PrudenteResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. s.prudente@css-mendel.it.ORCID http://orcid.org/0000-0001-9220-8981
Casa Sollievo della Sofferenza · ITSapienza University of Rome · ITJoslin Diabetes Center · USMagna Graecia University · ITOspedale di Santo Spirito · ITOspedale Sandro Pertini · ITOspedale Santa Maria Goretti · ITUniversità Campus Bio-Medico · ITUniversity of Cagliari · ITUniversity of Foggia · ITUniversity of L'Aquila · ITUniversity of Pisa · IT

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Italian Diabetes Society Fo.Ri.Sid/Ely-Lilly 2017Italian Ministry of Health Ricerca Corrente 2018-2021NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2AdultGenetic TestingHigh-Throughput Nucleotide SequencingHumansMutationEarly-onset type 2 diabetesMonogenic diabetesPrecision medicine

Identifiers

PMID35112188
PMCPMC12635930
OpenAlexW4210785837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.